MarketInOut Stock Screener Log In | Sign Up

PharmGen Science Inc

KRX • Healthcare • Drug Manufacturers - General • Quote as of 10/30/2026
PharmGen Science Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeKRX
Market Capitalization62,750 mln
Float17.33 mln

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-5.82
Highly reliable

Relative Strength

76 / 100
Strongly outperforming

Debt / Equity

0.01
Debt-free

Pre-Tax Margin

-80%
Severely loss-making

ROE

-56.20
Deeply negative

Business Description

Founded in 1957 and based in Hwaseong-si, South Korea, PharmGen Science Inc. is a long-established company that makes and sells a wide range of health and personal care products. Its lineup includes medicines available by prescription or over the counter, diagnostic kits, food supplements, cosmetics, and hair care items sold under the Neomcell brand.

Key Fundamentals

EPS-6,143
ROE-56.20
RPS9,471
ROIC1.28
ROA-42.11
Interest Cover8.60
EBITDA, mln-134,677
EV / EBITDA-0.33
EV / EBIT-0.32
Revenue, mln175,361
EV / Revenue0.25

Quote Details

Last 2,765.00
Change 15 (0.55%)
Open 2,735.00
Volume 23,019
Turnover 63,647,536
Average Volume 17,602

Financial Ratios

Pre-Tax Profit Margin-80
Leverage Ratio1.32
Current Ratio3.33
Price / Book0.47
Price / Tangible Book0.49
Price / Cash Flow3.54
Price / Free Cash Flow4.08
Debt / Equity0.01
Price / Sales0.35

Financial Strength

Altman Z-Score-0.19
Piotroski F-Score 5 / 9
Beneish M-Score-5.82
Price to Intrinsic Value0.78
Shiller PE Ratio13.37

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -0.36% 64 / 100   
1 Month -3.15% 71 / 100   
2 Months -20.55% 13 / 100   
6 Months -28.09% 46 / 100   
1 Year -32.23% 29 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog